Plasma pyridoxine deficiency is related to increased psychological distress in recently bereaved homosexual men

Psychosomatic Medicine

Volumn 60, Issue 3, 1998, Pages 297-308

  Baldewicz, Teri ^a,b   Goodkin, Karl ^a,b   Feaster, Daniel J ^b   Blaney, Nancy T ^b   Kumar, Mahendra ^b   Kumar, Adarsh ^b   Shor Posner, Gail ^b   Baum, Marianna ^b  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bereavement; Depression; Distress; HIV; Pyridoxine (vitamin B6); Serotonin

Indexed keywords

PYRIDOXINE;

ADULT; ARTICLE; BEREAVEMENT; CONTROLLED STUDY; EMOTIONAL STRESS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; SOCIAL ADAPTATION; SOCIAL SUPPORT; VITAMIN BLOOD LEVEL;

EID: 0031868713     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-199805000-00016     Document Type: Article

References (65)

1. 6. In Shils ME, Olson JA, Shike M (eds), Modern Nutrition in Health and Disease. 8th Edition. Philadelphia, Lea & Febiger, 1994, 383-394
2. Bender DA: Nutritional Biochemistry of the Vitamins. Cambridge, Cambridge University Press, 1992, 223-268
3. Adams PW, Rose DP, Folkard J, et al: Effects of pyridoxine hydrochloride upon depression associated with oral contraception. Lancet 1:897-904, 1973
4. 6 and the premenstrual syndrome. Int J Vit Nutr Res 27:213-224, 1985
5. 6 status on psychological distress in a longitudinal study of HIV-1 infection. Int J Psychiatry Med 24:209-222, 1994
6. Meltzer HY, Lowy MT: The serotonin hypothesis of depression. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, 513-526
7. Van Praag HM, Plutchik R, Conte H: The serotonin hypothesis of (auto)aggression. Critical appraisal of the evidence. Ann N Y Acad Sci 487:150-167, 1986
8. Syvalahti EKG: Biological aspects of depression. Acta Psychiatr Scand 377(Suppl):611-615, 1994
9. Higley JD, Mehlman PT, Taub DM, et al: Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch Gen Psychiatry 49:436-441, 1992
10. Virkkunen M, Rawlings R, Tokola R, et al: CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholics, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 51:20-27, 1994
11. Filteau M, Lapierre YD, Bakish D, et al: Reduction in suicidal ideation with SSRIs: A review of 459 depressed patients. J Psychiatry Neurosci 18:114-119, 1993
12. Goodnick PJ, Henry J, Kumar A: Neurochemistry and paroxetine response in major depression. Biol Psychiatry 37:417-419, 1995
13. Wurtman RJ: Food for thought. The Sciences 18:6-9, 1978
14. Young SN, Smith SE, Pihl RO, et al: Tryptophan depletion causes a rapid lowering of mood in normal subjects. Psychopharmacology 87:173-177, 1985
15. Delgado PL, Charney DS, Price LH, et al: Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411-418, 1990
16. Benkelfat C, Ellenbogen MA, Dean P, et al: Mood-lowering effect of tryptophan depletion: Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51:687-697, 1994
17. 6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr 4:1122-1132, 1991
18. Hodges RE, Bean WB, Ohlson MA, et al: Factors affecting human antibody response. IV. Pyridoxine deficiency. Am J Clin Nutr 11:180-186, 1962
19. Faustman WO, Faull KF, Whiteford HA, et al: CSF 5- HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression. Biol Psychiatry 27:311-318, 1990
20. 6 status and reaction time in early HIV-1 infection. Neurological and Neuropsycholological Complications of HIV Infection. Abstracts, 2:67, 1991
21. 6 supplementation in elderly men: Effects on mood, memory, performance and mental effort. Psychopharmacology 109:489-496, 1992
22. Charney DS, Woods SW, Krystal JH, et al: Serotonin function and human anxiety disorders. Ann NY Acad Sci 600:558-573, 1990
23. Mills KC: Serotonin syndrome. Clin Pharmacol 52:1475-1482, 1995
24. Goodkin K: A preliminary report of cross-sectional studies of stress, social support, and coping style indices in HIV spectrum disorders. Abstract of Papers. Washington, DC, AAAS Annual Meeting, 1989, 51-52
25. Goodkin K: Psychoneuroimmunology and viral infection with a special note on AIDS. In Balner H (ed), Publications of the Helen Dowling Institute for Biopsychosocial Medicine. 1. A New Medical Model. A Challenge for Biomedicine? Rockville, Swets & Zeitlinger, BV, 1990, 53-64
26. Blaney NT, Goodkin K, Morgan R, et al: A stress moderator model of distress in early HIV-1 infection: Concurrent analysis of life events, hardiness, and social support. J Psychosom Res 35:297-305, 1991
27. Goodkin K, Antoni MH, Sevin B, et al: A partially testable, predictive model of psychosocial factors in the etiology of cervical cancer. I. Biological, psychological, and social aspects. Psychooncology 2:79-98, 1993
28. Goodkin K, Antoni MH, Sevin B, et al: A partially testable, predictive model of psychosocial factors in the etiology of cervical cancer. II. Bioimmunological, psychoneuroimmunological, and socioimmunological aspects, critique and prospective integration. Psychooncology 2:99-121, 1993
29. Blaney NT, Goodkin K, Feaster D, et al: A psychosocial model of distress over time in early HIV-1 infection: The role of life stressors, social support, and coping. Psychol Health 12:633-653, 1997
30. Spitzer RL, Williams JBW, Gibbon M, et al: Structured Clinical Interview for DSM-III-R: Non-patient version for HIV studies (SCID-NP-HIV). New York, New York State Psychiatric Institute, 1988
31. Skala JH, Gretz D, Waring PP: An automated continuous flow procedure for simultaneous measurement of erythrocyte alanine and aspartate amino-transferase activities. Nutr Res 7:31-41, 1987
32. McNair DM, Lorr M, Droppleman LF: Manual for the Profile of Mood States. San Diego, CA, Educational and Industrial Testing Service, 1971
33. Sarason IG, Johnson JH, Siegel JM: Assessing the impact of life changes: Development of the life experiences survey. J Consult Clin Psychol 46:932-946, 1978
34. Sarason BR, Shearin, EN, Pierce GR, et al: Interrelations of social support measures: Theoretical and practical implications. J Pers Soc Psychol 52:813-832, 1987
35. Carver CS, Scheier MF, Weintraub JK: Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol 56:267-283, 1989
36. Tatsuoka MM: Multivariate analysis: Techniques for Educational and Psychological Research. 2nd Edition. New York, Macmillan, 1988
37. Lifshitz MS, de Cresce RP: The QM-300 protein analysis system. Clin Lab Med 8:633-642, 1988
38. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 4(No.RR:17):1-19, 1992
39. Centers for Disease Control: Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep 35:34-39, 1986
40. SAS Institute, Inc: SAS/STAT User's Guide. Version 6, 4th Edition, Vol 2. Cary, NC, SAS Institute, Inc., 1989
41. Steinfatt TM: The alpha percentage and experimentwise error rates in communication research. Hum Commication Res 5:366-374, 1979
42. Cravo ML, Gloria LM, Selhub J, et al: Hyperhomocysteinemia in chronic alcoholism: Correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr 63:220-224, 1996
43. Spurrell MT, Creed FH: Lymphocyte response in depressed patients and subjects anticipating bereavement. Br J Psychiatry 162:60-64, 1993
44. Baum M, Cassetti L, Bonvehi P, et al: Inadequate dietary intake and altered nutrition status in early HIV-1 infection. Nutrition 10:16-20, 1994
45. Chlebowski RT: Significance of altered nutritional status in acquired immunodeficiency syndrome. Nutr Cancer 7:85-91, 1985
46. 6 status of young men, women, and women using oral contraceptives. J Lab Clin Med 87:813-821, 1976
47. 6 Requirements. Washington, DC, National Academy of Sciences, 1978, 210-225
48. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC, American Psychiatric Press Inc, 1994
49. Wilkins JW, Robertson KR, Snyder CR, et al: Implications of self-reported cognitive and motor dysfunction in HIV-positive patients. Am J Psychiatry 148:641-643, 1991
50. Singer EJ, Wilkins J, Syndulko K, et al: Cerebrospinal fluid (CSF) biogenic amines increase and cortisol levels decrease after zidovudine (AZT) therapy in subjects with AIDS dementia complex (ADC). Neurological and Neuropsychological Complications of HIV Infection. Program and Abstracts, 1990, 145
51. Brouwers P, Heyes MP, Moss HA, et al: Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: Relationships to clinical status and therapeutic response. J Infect Dis 168:1380-1386, 1993
52. Heyes MP, Brew BJ, Martin A, et al: Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status. Ann Neurol 29:202-209, 1991
53. Wong MC, Suite NDA, Labar DR: Seizures in human immunodeficiency virus infection. Arch Neurol 47:640-642, 1990
54. Goodkin K: The neuropsychiatric and behavioral manifestations of HIV infection. In Florida Medical Association Sub-Committee on AIDS (ed), Clinical Manual on HIV and AIDS. An Update. Section IX, 2nd Edition. Jacksonville, Florida Medical Association, 1995, 113-131
55. Goodkin K: Complications of the central and peripheral nervous systems. In Forstein M (Chairman, Commission on AIDS, ed), HIV-Related Neuropsychiatric Complications and Treatments. HIV/AIDS Training Curriculum. Washington, DC, American Psychiatric Association, 1995, 1-103
56. Baumeister FA, Gsell W, Shin YS, et al: Glutamate in pyridoxine-dependent epilepsy: Neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine. Pediatrics 94:318-321, 1994
57. Petty F: GABA and mood disorders: A brief review and hypothesis. J Affect Disorders 34:275-281, 1995
58. Cleare AJ, Bond AJ: Effects of alterations in plasma tryptophan levels on aggressive feelings. Arch Gen Psychiatry 51:1004-1005, 1994
59. Cai Q, Huang X-L, Rappocciolo G, et al: Natural killer cell responses in homosexual men with early HIV infection. J Acquir Immune Defic Syndr 3:669-676, 1990
60. Trakatellis A, Dimitriadou A, Exindari M, et al: Effect of combination of deoxypyridoxine with known anti-proliferative or immunosuppressive agents on lymphocyte serine hydroxymethyltransferase. Postgrad Med J 70(Suppl 1):89-92, 1994
61. Goodkin K, Blaney NT, Feaster D, et al: Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men. J Psychosom Res 36:635-650, 1992
62. Goodkin K, Feaster DJ, Tuttle R, et al: Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic HIV-1 seropositive homosexual men. Clin Diag Lab Immunol 3:109-118, 1996
63. Fernandez F, Adams F, Levy JK: Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics 29:38-46, 1988
64. Farzadegan H, Polis MA, Wolinsky SM, et al: Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. Ann Intern Med 108:785-790, 1988
65. Root-Bernstein RS: Five myths about AIDS that have misdirected research and treatment. Genetica 95:111-132, 1995